Apply on Employer Site

Enveda · 6 hours ago

Metabolomics Scientist

Boulder, CO

Full-time

Onsite

Entry, Mid Level

$131K/yr - $140K/yr

2+ years exp

Enveda is a company focused on transforming natural compounds into life-changing medicines. As a Metabolomics Scientist, you will leverage your expertise in metabolite annotation to enhance the company's metabolomics capabilities, partnering with various scientific teams to translate insights into actionable therapeutic information.

BiotechnologyPharmaceuticalTherapeutics

H1B Sponsor Likely

Responsibilities

Serve as a subject-matter expert in metabolite annotation and identification from LC-MS-based metabolomics data

Lead follow-up investigations on mis-annotations and unknown features

Build, curate, and maintain internal spectral libraries to strengthen metabolite annotation capabilities

Contribute to data QC, review, and troubleshooting, helping to continuously improve robustness and reproducibility of the platform

Qualification

Metabolite annotationLC-MS-based metabolomicsMetabolomics data processingLarge-scale metabolomics studiesPhD in chemistry

Required

PhD in chemistry or a related scientific discipline with 2+ years of experience in LC-MS-based metabolomics

Strong expertise in metabolite annotation and identification

Proficiency with one or more metabolomics data processing tools (e.g., MZmine, XCMS, MS-DIAL, MetaboScape)

Hands-on experience with large-scale metabolomics studies, ideally involving human biospecimens

Benefits

90% Medical, Dental, Vision

401k Match

Flexible PTO

Adoption Assistance

Company

Enveda

Enveda is a biotechnology company that is learning from life’s chemistry to create better medicines faster.

Founded in 2019

Boulder, Colorado, USA

201-500 employees

https://enveda.com

H1B Sponsorship

Enveda has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)

Distribution of Different Job Fields Receiving Sponsorship

Represents job field similar to this job

Trends of Total Sponsorships

2025 (2)

2024 (2)

2023 (1)

2022 (5)

Funding

Current Stage

Late Stage

Total Funding

$529.9M

Key Investors

Premji InvestSanofiKinnevik

2025-09-04Series D· $150M

2025-02-26Series C· $20M

2024-11-21Series C· $130M

Leadership Team

Viswa Colluru

CEO & Founder

August Allen

Chief Technology Officer

Recent News

GlobeNewswire

Phlow and Enveda Partner to Advance AI-Driven Chemistry to Accelerate Domestic Pharmaceutical Development and Transform Drug Substance Manufacturing

2026-01-16

BizWest

Enveda inflammatory bowel disease drug candidate cleared for trial

2026-01-06

Morningstar.com

Enveda Advances Third Asset to the Clinic With US FDA IND Clearance and Phase 1 Initiation of ENV-6946, a First-in-Class Oral “Multi-Biologic in a Pill” for Inflammatory Bowel Disease

2025-12-24

Company data provided by crunchbase